We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Research Reports for UnitedHealth, Netflix & Pepsi
Read MoreHide Full Article
Tuesday June 20 2017
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH - Free Report) , Netflix (NFLX - Free Report) and Pepsi (PEP - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
UnitedHealth’s continued strong growth at Optum as well as UnitedHealthcare segments are driving growth. The buy-rated stock’s international business and strong capital position are other positives. Moreover, the company has reduced its exposure to the troubled public exchange business.
Though this move will shield it from losses in this business, the company’s premium revenues are likely to be affected. UnitedHealth shares have underperformed the Zacks Medical-HMOs industry in the year-to-date period (up +14.4% vs. +19.2%).
Shares of Buy-rated Netflix have gained +68.6% over the past 12 months, outperforming the Zacks Broadcast Radio/TV industry, which has gained +22.3% over the same period. Netflix’s focus on global expansion and original content has paid off with the streaming giant adding 4.95 million net new additions in the last reported quarter, taking the total count to 98.75 million.
Going forward, the company expects to add 0.60 million subscribers in the domestic streaming segment and 2.60 million subscribers in the international segment in the second quarter. The company’s efforts to attract viewers through investing in more regional programming should also boost user base. Estimates have remained stable ahead of the upcoming earnings release.
Pepsi’s shares modestly lagged the broader market over the last year (+12.6% for PEP vs. +17.6% for the S&P 500), but they outperformed the Zacks Soft Drinks Beverages industry as well as Coke (KO was +0.6%). Despite global macro challenges, Pepsi has been doing well since 2014 on the back of significant innovation, ongoing revenue management strategies, improved productivity and better market execution.
The company has been facing challenges amid the shift in consumers’ preferences. Given this backdrop, it is gradually reshuffling its portfolio toward healthier “Everyday Nutrition Products” in order to adapt to the changing customer needs of healthier lifestyles. However, apart from sluggish CSD volumes, rising volatility in global markets and increasing currency headwinds may limit top line growth.
Zacks just released a Special Report to guide you through a space that has already begun to transform our entire economy...
Last year, it was generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. Download Report with 3 Top Tech Stocks >>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Previewreports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Research Reports for UnitedHealth, Netflix & Pepsi
Tuesday June 20 2017
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH - Free Report) , Netflix (NFLX - Free Report) and Pepsi (PEP - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
UnitedHealth’s continued strong growth at Optum as well as UnitedHealthcare segments are driving growth. The buy-rated stock’s international business and strong capital position are other positives. Moreover, the company has reduced its exposure to the troubled public exchange business.
Though this move will shield it from losses in this business, the company’s premium revenues are likely to be affected. UnitedHealth shares have underperformed the Zacks Medical-HMOs industry in the year-to-date period (up +14.4% vs. +19.2%).
(You can read the full research report on UnitedHealth here >>>).
Shares of Buy-rated Netflix have gained +68.6% over the past 12 months, outperforming the Zacks Broadcast Radio/TV industry, which has gained +22.3% over the same period. Netflix’s focus on global expansion and original content has paid off with the streaming giant adding 4.95 million net new additions in the last reported quarter, taking the total count to 98.75 million.
Going forward, the company expects to add 0.60 million subscribers in the domestic streaming segment and 2.60 million subscribers in the international segment in the second quarter. The company’s efforts to attract viewers through investing in more regional programming should also boost user base. Estimates have remained stable ahead of the upcoming earnings release.
(You can read the full research report on Netflix here >>>).
Pepsi’s shares modestly lagged the broader market over the last year (+12.6% for PEP vs. +17.6% for the S&P 500), but they outperformed the Zacks Soft Drinks Beverages industry as well as Coke (KO was +0.6%). Despite global macro challenges, Pepsi has been doing well since 2014 on the back of significant innovation, ongoing revenue management strategies, improved productivity and better market execution.
The company has been facing challenges amid the shift in consumers’ preferences. Given this backdrop, it is gradually reshuffling its portfolio toward healthier “Everyday Nutrition Products” in order to adapt to the changing customer needs of healthier lifestyles. However, apart from sluggish CSD volumes, rising volatility in global markets and increasing currency headwinds may limit top line growth.
(You can read the full research report on Pepsi here >>>).
Other noteworthy reports we are featuring today include Qualcomm (QCOM - Free Report) , Occidental (OXY - Free Report) and Phillips 66 (PSX - Free Report) .
3 Top Picks to Ride the Hottest Tech Trend
Zacks just released a Special Report to guide you through a space that has already begun to transform our entire economy...
Last year, it was generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. Download Report with 3 Top Tech Stocks >>
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>